Abstract:Objective To evaluate clinical significance of platelet/lymphocyte ratio ( PLR) in the differentiation and severity determination of ulcerative colitis .Methods One hundred and ninety-two patients who sought medical care from June 2009 to June 2016, in Changhai Hospital , were enrolled as study subjects , of whom 97 were patients with ulcerative colitis and 95 were patients with irritable bowel syndrome .Differences in PLR between the 2 groups were analyzed and the sensitivity and specificity of PLR in the diag-nosis of ulcerative colitis were also evaluated .Through the modified Mayo score system , the activity of ulcerative colitis was evaluated , and pathological spreading site was determined by colonoscopy , and the correlation between PLR and disease activity and pathological spreading site was evaluated .Results As compared with those of the control group with irritable bowel syndrome , the while blood cell counts, blood platelet counts , PLR, the erythrocyte sedimentation rate and the C-reaction protein of the patients with ulcerative colitis were significantly increased, and statistical significance could be noted when comparisons were made between them (P<0.05).Statis-tical significance could be found in PLR differences between the ulcerative colitis patients and irritable bowel syndrome patients .ROC a-nalysis indicated that sensitivity and specificity of the PLR biomarker were respectively 67%and 58%.PLR data for the patients with irritable bowel syndrome and those with light , moderate and severe ulcerative colitis were 123.73 ±60.47, 114.32 ±43.66, 160.19 ± 56.52 and 253.35 ±86.82 respectively.Results indicated that there was no statistical significance in the clinical data between irritable bowel syndrome and light ulcerative colitis (P=0.54).However, statistical significance could be noted in the data between irritable bowel syndrome and moderate/severe ulcerative colitis(P<0.05).Statistical significance could all be seen in the differences of the clinical data between light, moderate and severe ulcerative colitis (P<0.05).But there was no statistical difference in PLR between different pathological lesions in the patients with ulcerative colitis (P>0.05).Conclusion PLR has certain clinical value and signifi-cance in the identification and diagnosis of ulcerative colitis and irritable bowel syndrome , and at the same time , it could evaluate the degree of inflammation of ulcerative colitis .

Platelet-to-Lymphocyte Ratio as an Independent Factor Was Associated With the Severity of Ankylosing Spondylitis

Neutrophil- and Platelet-to-lymphocyte Ratios Are Correlated with Disease Activity in Rheumatoid Arthritis.

Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios As Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis

Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients

Platelet to Albumin Ratio is an Independent Indicator for Disease Activity in Ankylosing Spondylitis.

High Levels of Platelet-to-lymphocyte Ratio May Predict Reduced Risk of End Stage of Renal Disease in Chinese Patients with MPO-ANCA Associated Vasculitis.

Changes Of Neutrophil-To-Lymphocyte Ratio And Red Blood Cell Distribution Width In Ankylosing Spondylitis

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis

Platelet to Lymphocyte Ratio in the Prediction of Adverse Outcomes after Acute Coronary Syndrome: A Meta-Analysis

Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans

Tumor Necrosis Factor Alpha -308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis

[Association Between Platelet-to-lymphocyte Ratio and Neutrophil-to-lymphocyte Ratio with Disease Activity in Takayasu Arteritis Patients].

Clinical significance of platelet/lymphocyte ratio in the differentiation and severity determination of ulcerative colitis

Association Between Blood PLT and RBC Related Indices and Disease Activity in Patients with Rheumatoid Arthritis

Platelet-to-lymphocyte ratios as a haematological marker of synovitis in rheumatoid arthritis with normal acute phase reactant level

Clinical Significance of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in ANCA-Associated Vasculitis: A Retrospective Study

The Prognostic Value of the Platelet-To-Lymphocyte Ratio in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients

Application Value of Platelet-to-Lymphocyte Ratio as a Novel Indicator in Rheumatoid Arthritis: A Review Based on Clinical Evidence

Platelet-to-lymphocyte Percentage Ratio for Assessing Disease Activity and Predicting Therapeutic Outcomes in Ulcerative Colitis